Gut Microbiota

News Watch

After the success of the First Gut Microbiota for Health Summit (Evian, March 2012), the second edition has been planned for February 2013. From the 24th to the 26th of February, Madrid (Spain) will be the capital of gut microbiota. This international event will gather more than 200 scientists from different fields of expertise who are leading the latest discoveries…

GMFH Editing Team
GMFH Editing Team

After the success of the First Gut Microbiota for Health Summit (Evian, March 2012), the second edition has been planned for February 2013. From the 24th to the 26th of February, Madrid (Spain) will be the capital of gut microbiota. This international event will gather more than 200 scientists from different fields of expertise who are leading the latest discoveries…

GMFH Editing Team
GMFH Editing Team

In this interview, Prof. James Versalovic says that, as for the Human Genome Project, we’re only witnessing the first steps of gut microbiota research. In the course of the past few years, the scientific question has evolved from “what bacteria live with us?” to “what do they do?”, a key element when trying to define the gut microbiota as a multi-cellular microbial…

GMFH Editing Team
GMFH Editing Team

In this interview, Prof. James Versalovic says that, as for the Human Genome Project, we’re only witnessing the first steps of gut microbiota research. In the course of the past few years, the scientific question has evolved from “what bacteria live with us?” to “what do they do?”, a key element when trying to define the gut microbiota as a multi-cellular microbial…

GMFH Editing Team
GMFH Editing Team

Great projects such as Human Microbiome Project and MetaHIT have arrived to the end in the last two years, but it doesn’t mean research on gut microbiota stops. A second generation of studies has started, evidencing the relevance of this topic. Scientist are focusing on gut microbiota, increasing the current knowledge about its importance and relation with our health and…

GMFH Editing Team
GMFH Editing Team

Great projects such as Human Microbiome Project and MetaHIT have arrived to the end in the last two years, but it doesn’t mean research on gut microbiota stops. A second generation of studies has started, evidencing the relevance of this topic. Scientist are focusing on gut microbiota, increasing the current knowledge about its importance and relation with our health and…

GMFH Editing Team
GMFH Editing Team

The year 2012 is coming to an end and we would like to take this opportunity to remind everyone why we believe that it has been the year of the gut microbiota. Back in 2011, the European Society for Neurogastroenterology & Motility created the Gut Microbiota and Health Section to focus on this field. The launch of this new section,…

GMFH Editing Team
GMFH Editing Team

The year 2012 is coming to an end and we would like to take this opportunity to remind everyone why we believe that it has been the year of the gut microbiota. Back in 2011, the European Society for Neurogastroenterology & Motility created the Gut Microbiota and Health Section to focus on this field. The launch of this new section,…

GMFH Editing Team
GMFH Editing Team

Today we want to share with you a TED video where the scientist Bonnie Bassler explains How bacteria can “talk”. She studies how bacteria can communicate with one another, through chemical signals, to act as a unit. This video is from 2009, and yet then her work was seen as crucial in the development of more potent medicine. During this…

GMFH Editing Team
GMFH Editing Team

Today we want to share with you a TED video where the scientist Bonnie Bassler explains How bacteria can “talk”. She studies how bacteria can communicate with one another, through chemical signals, to act as a unit. This video is from 2009, and yet then her work was seen as crucial in the development of more potent medicine. During this…

GMFH Editing Team
GMFH Editing Team

Research & Practice

Previous research has shown that human gut microbial communities may be grouped into three types-called enterotypes-driven by high abundances of Bacteroides (enterotype 1), Prevotella (enterotype 2) and Ruminococcus (enterotype 3). Although gut microbiota may mediate the relationship between dietary habits and cardiovascular diseases, the role of enterotypes in understanding mechanisms linking dietary habits to cardiometabolic diseases has not been explored…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Previous research has shown that human gut microbial communities may be grouped into three types-called enterotypes-driven by high abundances of Bacteroides (enterotype 1), Prevotella (enterotype 2) and Ruminococcus (enterotype 3). Although gut microbiota may mediate the relationship between dietary habits and cardiovascular diseases, the role of enterotypes in understanding mechanisms linking dietary habits to cardiometabolic diseases has not been explored…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Gut microbiota dysbiosis, which has been defined as “the altered proportion and activity of bacterial groups of gut microbiota”, is suspected to be involved in several metabolic diseases such as hepatic steatosis, type 2 diabetes, and obesity. However, the underlying mechanisms are still a matter of debate. In a recent study, led by Dr. Matteo Serino from the Institut Nacional…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Gut microbiota dysbiosis, which has been defined as “the altered proportion and activity of bacterial groups of gut microbiota”, is suspected to be involved in several metabolic diseases such as hepatic steatosis, type 2 diabetes, and obesity. However, the underlying mechanisms are still a matter of debate. In a recent study, led by Dr. Matteo Serino from the Institut Nacional…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Faecal microbiota transplantation (FMT) is a therapy targeting the gut microbiome with the strongest evidence for efficacy in the treatment of recurrent Clostridium difficile infection. Although gut microbiota dysbiosis is involved in the pathogenesis of ulcerative colitis, the role of FMT as a therapy for it is still controversial as the two big randomised controlled trials done previously (here; here)…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Faecal microbiota transplantation (FMT) is a therapy targeting the gut microbiome with the strongest evidence for efficacy in the treatment of recurrent Clostridium difficile infection. Although gut microbiota dysbiosis is involved in the pathogenesis of ulcerative colitis, the role of FMT as a therapy for it is still controversial as the two big randomised controlled trials done previously (here; here)…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Hepatic encephalopathy is a brain dysfunction involving neurological and psychiatric changes associated with liver insufficiency or portal-systemic shunting with a severity that ranges from minor symptoms to coma. There have been reported differences in gut microbiota between those with and without hepatic encephalopathy. A previous Cochrane systematic review including 38 randomised clinical trials on non-absorbable disaccharides (lactulose and lactitol) versus…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Hepatic encephalopathy is a brain dysfunction involving neurological and psychiatric changes associated with liver insufficiency or portal-systemic shunting with a severity that ranges from minor symptoms to coma. There have been reported differences in gut microbiota between those with and without hepatic encephalopathy. A previous Cochrane systematic review including 38 randomised clinical trials on non-absorbable disaccharides (lactulose and lactitol) versus…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Celiac disease (CeD) is a complex immune mediated disorder that is triggered by abnormal immune responses to the dietary protein gluten, which is found in grains like wheat, barley, and rye. Normally, immune tolerance to dietary proteins prevents inflammatory immune responses from developing. However, in those with CeD, the presence of HLA susceptibility genes plus unknown environmental or immune triggers…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.

Celiac disease (CeD) is a complex immune mediated disorder that is triggered by abnormal immune responses to the dietary protein gluten, which is found in grains like wheat, barley, and rye. Normally, immune tolerance to dietary proteins prevents inflammatory immune responses from developing. However, in those with CeD, the presence of HLA susceptibility genes plus unknown environmental or immune triggers…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.